LINC01311: A Drug Target / Disease Biomarker (G100652736)

Target Name: LINC01311

NCBI ID: G100652736

LINC01311

Other Name(s): Long intergenic non-protein coding RNA 1311 | long intergenic non-protein coding RNA 1311

LINC01311: A Drug Target / Disease Biomarker

LINC01311 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of LINC01311 is its ability to interact with other proteins, particularly the transcription factor PDGF-BB. PDGF-BB is a potent regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

LINC01311 has been shown to play a role in the regulation of PDGF-BB signaling in various tissues, including the brain. For example, studies have shown that LINC01311 can physically interact with PDGF-BB in the brain, and that this interaction is important for the regulation of neuronal growth and differentiation.

In addition to its role in PDGF-BB signaling, LINC01311 has also been shown to play a number of other roles in the regulation of cell growth and differentiation. For example, it has been shown to play a role in the regulation of cell adhesion, cell migration, and the formation of tissues such as the placenta and the liver.

LINC01311 has also been shown to be involved in the regulation of inflammation, and has been implicated in the development of a number of autoimmune diseases. For example, studies have shown that LINC01311 is involved in the regulation of the immune response, and that this regulation is important for the development of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

In conclusion, LINC01311 is a protein that has been shown to play a number of important roles in the regulation of cell growth and differentiation, and is therefore a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the mechanisms of LINC01311's role in these processes, and to develop effective treatments for those who are affected by these diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 1311

The "LINC01311 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01311 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets